Ozempic Now Approved Page for HCPs Jan 8, 2018Jan 4, 2018 Brand: Ozempic (semaglutide), Injection Parent Company: Novo Nordisk Drug Type: Boxed Warning Drug Category: Endocrinology Campaign: now-approved Targeting: HCPs Patient Website: HCP Website: https://www.ozempicpro.com/ Entry Modal Now Approved Page Study Selector